Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Specialized management of severe hypoglycaemia in type 1 diabetes: education, technology and transplantation

Symposium
James Shaw is Professor of Regenerative Medicine for Diabetes at Newcastle University and Honorary Consultant Physician at the Newcastle Diabetes Centre and Freeman Hospital. He chairs the United Kingdom Islet Transplant Consortium and he is Principal Investigator on the first UK multicentre grants to determine psychosocial and biomedical outcomes of islet transplantation. Professor Shaw remains a committed physician, indebted to his multidisciplinary team and dedicated to supporting those with diabetes.

Speaker

Prof James Shaw, Newcastle University, UK

Recent publications

Loss of end-differentiated ß-cell phenotype following pancreatic islet transplantation. Anderson SJ, White MG, Armour SL, Maheshwan R, Tiniakos D, Muller YD, Berishvili E, Berney T, Shaw JAM. Am J Transplant. 2018 Mar;18(3);750-755. doi: 10.1111/ajt. 14521. Epub 2017 Oct 17.4.

Donor-Specific Antibodies - The Devil Is in teh Detail. Carter V, Howell WM, Shaw JAM. Am J Transplant. 2017 Jul;17(7):1959. doi: 10.1111/ajt.14253. Epub 2017 Mar 23.

Host

Lena Eliasson

Time: 
4 May 2018 14:00 to 15:00
Location: 
Medelhavet lecture hall, Wallenberg lab, SUS Malmö
Contact: 
ulrika.blom-nilsson [at] med.lu.se

About the event

Time: 
4 May 2018 14:00 to 15:00
Location: 
Medelhavet lecture hall, Wallenberg lab, SUS Malmö
Contact: 
ulrika.blom-nilsson [at] med.lu.se

Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00